Join Drs. Glesby and Stein as they review evidence for managing HIV-infected patients with dyslipidemia-should one switch antiretroviral therapy or add lipid-lowering agents?
Registration for this activity is open to physicians and healthcare professionals actively involved in the delivery of care to HIV-infected patients. Other restrictions may apply.
Faculty
Marshall J. Glesby, MD, PhD
Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Medical College of Cornell University
New York, New York
James H. Stein, MD
Professor of Medicine
Cardiovascular Medicine Division
Director
Preventive Cardiology
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin